Global Transient Ischemic Attack (TIA) Market, By Treatment (Anti-platelet Drugs, Anticoagulants, Surgery, Angioplasty, Others), Diagnosis (Carotid ultrasonography, MRI, CT scan, Echocardiography, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Tingling, Dysphasia, Weakness, Dysarthria, Confusion, Vision Changes, Balance Issues, Headache, Dizziness, An abnormal sense of taste and smell, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Transient Ischemic Attack (TIA) Market
Transient ischemic attack (TIA) market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.60% in the above mentioned forecast period.
Transient ischemic attack (TIA) is defined as a stroke that develops due to the blockage in blood flow to the brain. It occurs for short period of time as blood supply is restored quickly and prevents the death of brain tissue. It is caused due to blood clots that get trapped in the artery which supplies blood to the brain. It is characterised by tingling, dysphasia, weakness, dysarthria, confusion, vision changes, an altered level of consciousness, balance issues, headache, dizziness and an abnormal sense of taste and smell. This condition is also called mini stroke.
Rise in the prevalence of chronic disorders, cardiovascular diseases and neurological diseases, faulty dietary habits, and sedentary lifestyles are the major factors influencing the market growth rate. Furthermore, favorable reimbursement scenarios, growing demand for minimally invasive procedures and rising initiatives by government and private organizations to spread awareness about the disease and its available treatment are the factors that will expand the transient ischemic attack (TIA) market.
The rise in the investments for R&D activities by government organizations and technological advancement will provide beneficial opportunities for the transient ischemic attack (TIA) market in the forecast period of 2021-2028.
However, high cost of treatment and lack of awareness about the diagnosis and treatment of TIA are the factors that will hinder the market growth. Lack of skilled physicians will challenge the transient ischemic attack (TIA) market in the forecast period mentioned above.
This transient ischemic attack (TIA) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transient ischemic attack (TIA) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Transient Ischemic Attack (TIA) Market Scope and Market Size
The transient ischemic attack (TIA) market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the transient ischemic attack (TIA) market is segmented into anti-platelet drugs, anticoagulants, surgery, angioplasty and others. Anti-platelet drugs have been further sub-segmented into aspirin, prasugrel, clopidogrel and aspirin-dipyridamole. Anticoagulants have been further sub-segmented into rivaroxaban, warfarin and apixaban.
- On the basis of diagnosis, the transient ischemic attack (TIA) market is segmented into carotid ultrasonography, MRI, CT scan, echocardiography and others.
- On the basis of dosage, the transient ischemic attack (TIA) market is segmented into tablet, injection and others.
- On the basis of route of administration, the transient ischemic attack (TIA) market is segmented into oral, intravenous and others.
- On the basis of symptoms, the transient ischemic attack (TIA) market is segmented into tingling, dysphasia, weakness, dysarthria, confusion, vision changes, balance issues, headache, dizziness, an abnormal sense of taste and smell and others.
- On the basis of end-users, the transient ischemic attack (TIA) market is segmented into clinic, hospital and others.
The transient ischemic attack (TIA) market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Transient Ischemic Attack (TIA) Market Country Level Analysis
Transient ischemic attack (TIA) market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.
The countries covered in the transient ischemic attack (TIA) market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the transient ischemic attack (TIA) market due to the presence of major key players, high disposable income and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Transient ischemic attack (TIA) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Transient Ischemic Attack (TIA) Market Share Analysis
Transient ischemic attack (TIA) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global transient ischemic attack (TIA) market research.
The major players covered in the transient ischemic attack (TIA) market report are Abbott, Bayer AG, Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, DAIICHI SANKYO COMPANY, LIMITED., Boston Scientific Corp., electroCore, Inc., Cardinal Health, Cigna, Eli Lilly and Company, GENERAL ELECTRIC, LivaNova PLC, Medtronic, Merck KGaA, Novo Nordisk A/S, Siemens Healthcare GmbH, Stryker, Terumo Corporation, Zocere, Inc., Boehringer Ingelheim International GmbH., Johnson & Johnson Private Limited, and Bristol-Myers Squibb Company, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-